FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to racemic 3,17β-dihydroxy-7α,18-dimethyl-6-oxaextra-1,3,5(10),8(9)-tetraene diacetate of formula 
.
EFFECT: production of the substance exhibiting osteoprotective, hypocholesteremic and antioxidant action with lowered uterotropic activity.
1 cl, 2 ex, 2 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| 3-METHOXY-2-FLUORO-18-ETHYL-8α-GONA-1,3,5( 10 )-TRIENES, HAVING OSTEOPROTECTOR AND HYPOCHOLESTEREMIC ACTIVITY | 2009 |
|
RU2418000C1 |
| 13-ETHYL-GONA-1,3,5( 10), 8 (9)-TETRAENE-3,17β-DIOL DIACETATE, HAVING ANTI-IMPLANTATION AND ANTIOXIDANT ACTIVITY | 2010 |
|
RU2454424C1 |
| RACEMIC 3-HYDROXY-16-METHYL-2-FLUORO-13a-ESTRA-1,3,5(10),8(9),15-PENTAEN-17-ONE AS MEANS OF HORMONE REPLACEMENT THERAPY AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2526264C1 |
| 15β-SUBSTITUTED STEROIDS WITH SELECTIVE OESTROGENIC ACTIVITY | 2005 |
|
RU2386637C2 |
| METHYL ETHER OF 16,16-DIMETHYL-2-FLUORO-D-HOMO-8ALPHA-OESTRONE, HAVING HYPOLIPIDEMIC AND CARDIOPROTECTOR ACTIVITY | 2010 |
|
RU2436792C1 |
| USE OF 3-O-SULFAMOYLOXY-7Β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE FOR THE TREATMENT OF BREAST CANCER, INCLUDING A TRIPLE NEGATIVE FORM | 2018 |
|
RU2678845C1 |
| PROCESS FOR PREPARING RACEMIC 8-ISOESTRADIOL | 0 |
|
SU1092158A1 |
| 17,17-DIMETHYL-D-HOMO-B-NOR-8α-OESTRONE HAVING HYPOLIPIDEMIC AND CARDIOPROTECTOR ACTIVITY | 2008 |
|
RU2391351C1 |
| COMPOUNDS WITH HYDROXYCARBONYL-HALOGENALKYL BY-SIDE CHAINS | 2000 |
|
RU2247106C2 |
| DERIVATIVES OF ESTRA-1,3,5(10)-TRIENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2139885C1 |
